Published July 2004 | Version v1
Report Metadata-only

Clinical results of carbon ion radiotherapy for CNS tumor

Creators

  • 1. National Inst. of Radiological Sciences, Chiba (Japan). Research Center Hospital for Charged Particle Therapy
  • 2. Tokyo Women's Medical Coll. (Japan)

Description

Preliminary results of combined therapy of X-ray, nimustine (ACNU) and carbon ion radiotherapy show the clinical utility of carbon ion radiotherapy for malignant gliomas because of the increased local control and survival rate according to the carbon ion doses. These results led to a new protocol for malignant gliomas treated only with carbon ion radiotherapy from April 2002. Carbon ion radiotherapy for skull base tumors is feasible and well tolerated, because the preliminary results of treatment show a high local control rate and survival rate without unacceptable normal tissue morbidity. (author)

Part of:
Ten years' history of HIMAC

Additional details

Publishing Information

Imprint Title
Ten years' history of HIMAC
Imprint Pagination
345 p.
Journal Page Range
p. 59-67
Report number
NIRS-M--177

INIS

Country of Publication
Japan
Country of Input or Organization
Japan
INIS RN
36090649
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
ASTROCYTOMAS; CARBON IONS; CEREBRUM; CLINICAL TRIALS; FRACTIONATED IRRADIATION; PATIENTS; RADIATION DOSE DISTRIBUTIONS; RADIATION DOSES; RADIOTHERAPY; SURVIVAL CURVES
Descriptors DEC
BODY; BRAIN; CENTRAL NERVOUS SYSTEM; CHARGED PARTICLES; DISEASES; DOSES; GLIOMAS; IONS; IRRADIATION; MEDICINE; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; TESTING; THERAPY

Optional Information

Secondary number(s)
HIMAC--093